Papa Medical Inc. (PAPA)
Papa Medical will go public soon, but the exact IPO date is still unknown.
IPO Price
$4.00
Shares Offered
1,250,000
Deal Size
$5.00M
Company Description
Papa Medical is the first end-to-end innovative cannabis dosing solution provider in the US that possesses the medical atomization or nebulizing background and sells nebulizer, according to the Frost & Sullivan Report.
We deeply engage in the key activities in the cannabis and consuming E-vapors industry, from the research and development, formulation design, e-liquid production, e-liquid filling to e-liquid co-packing services.
We believe our full-cycle operations and leading market position will position us to further capitalize on the growth potential of US’ cannabis E-vapors market.
Papa Medical Inc.
| Country | United States |
| Founded | 2018 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 38 |
| CEO | Jian Hua |
Contact Details
Address: 202 North California Ave City of Industry, California 91744 United States | |
| Phone | (626) 855-0800 |
Stock Details
| Ticker Symbol | PAPA |
| Exchange | NASDAQ |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0002024283 |
| Employer ID | 99-0986423 |
| SIC Code | 2111 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jian Hua | Chief Executive Officer and Chairman of Board of Directors |
| Ms. Lina Song | Director and Chief Technology Officer |
| Ms. Fei Xu | Director and General Manager |
| Mr. Joel Adalberto Gallo | Independent Director and Chair of the Audit Committee |
| Mr. Douglas Bruce Noyes | Independent Director and Chair of the Nominations Committee |
| Dr. James Jiayuan Tong | Independent Director and Chair of the Compensation Committee |
| Ms. Hua Yao | Chief Financial Officer |
| Mr. Weilin Ye | Deputy Chief Financial Officer |
| Mr. Johnathan Lin | Chief Operating Officer and Human Resource Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 18, 2025 | 8-A12B | Registration of securities |
| Jul 14, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jun 27, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Nov 22, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Oct 7, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jul 31, 2024 | DRS | [Cover] Draft Registration Statement |